Drug Plan Management

2016 DRUG TRENDS AT A GLANCE (Express Scripts Report)


EXECUTIVE SUMMARY In 2016, Express Scripts Canada’s analysis of private-plan spending trends once again reflected opposing cost forces.  Factors driving an increase in drug spend have outweighed downward pressure on drug costs. At the same time, high-cost drugs and high-cost patients continued to create troubling trend acceleration. These new medicines offer high cure rates for [...]

2016 DRUG TRENDS AT A GLANCE (Express Scripts Report)2018-04-17T15:54:35+00:00

Dealing with Biosimilars


From time to time, Insurers can do a particularly good job of communicating a particular strategy or educating plan sponsors on a particular topic.  This month (April 2016) Green Shield Canada came out with a very good document outlining their position and possibly that of their competitors with respect to the treatment of "generic" or [...]

Dealing with Biosimilars2018-04-17T15:55:12+00:00

Drug Spend Needs To Be Managed


This was a reporters take on a seminar presentation by Chris Pryce made at the Bellagio Event Venue (March 2nd, 2016) in front of an audience of some 200 plus Advisors, Consultants, Pharmaceutical and Third Party Administrators. In the News - March 3, 2016 (Benefits and Pension Monitor) http://www.bpmmagazine.com/benefits_news.php Advisors need to dare to be different [...]

Drug Spend Needs To Be Managed2018-04-17T15:55:12+00:00

Express Script 2013 Drug Trend Report Summary


The Express Script report is 86 pages and although it makes for great reading, the skinny essentials were noted on the 1st couple of pages of the report (excerpted below): Executive Summary / Trends and a Glance According to the Express Script report, prescription drugs play an important and increasingly essential role in reducing the impact [...]

Express Script 2013 Drug Trend Report Summary2018-04-17T15:55:13+00:00
Go to Top